GlassScriptPhysician profile
Raza Yunus
NPI 1225475973
$2,702.12
in general payments reported to CMS, 2019-2025
20 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $690 · 2021: $637 · 2022: $475 · 2023: $346 · 2024: $38.91 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $695.96 | 2019-2020 | |
| Abbott Laboratories | $368.67 | 2021-2025 | Assurity, Thoratec Heartmate 3 Lvas Implant Kit |
| Asahi Intecc USA, INC. | $285.56 | 2020-2021 | |
| Cardiovascular Systems INC. | $264.72 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $205.07 | 2021-2023 | Xarelto |
| Medtronic, INC. | $185.85 | 2021-2023 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.48 | 2020-2023 | Lifevest |
| Philips North America LLC | $105.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $78.05 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $64.92 | 2022-2023 | Brilinta, Farxiga |
| Teleflex LLC | $60.67 | 2021-2025 | Guideliner |
| Penumbra, INC. | $49.38 | 2023 | Indigo System |
| Abiomed | $42.06 | 2023-2025 | Impella |
| Shockwave Medical, INC | $36.39 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $32.01 | 2023 | Eliquis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $27.12 | 2025 | Metacross Otw |
| Boston Scientific Corporation | $21.06 | 2024 | Avvigo Guidance System |
| Pfizer INC. | $17.79 | 2021 | |
| Lemaitre Vascular, INC. | $15.65 | 2023 | Artegraft Vascular Graft |
| Biotronik INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raza Yunus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.